Category: Science Blog November 14, 2014
We’ve launched three exciting crowdfunding projects with our researchers. Will they receive the money they need? Only you can decide.
Category: Science Blog October 27, 2014
We take a look at what the recently published NHS ‘Five Year Forward View’ means for cancer care within the health service in England.
Category: Science Blog October 24, 2014
Olaparib is the first PARP inhibitor to move closer to licensing in Europe. What is it, how does it work, and when will it be available in the UK?
Category: Science Blog October 21, 2014
Our latest funding scheme focuses on the emerging field of biotherapeutics – smarter cancer treatments based on cells and biological molecules.